Navigation Links
Seahorse Bioscience - Growing in a World of Budget Constraints

BILLERICA, Mass., Sept. 23, 2013 /PRNewswire/ -- In an invited talk at Europe's 2013 MipTec Conference and Exhibition, Seahorse Bioscience Chief Executive Officer, Jay Teich, will discuss the factors that enabled Seahorse to maintain steady growth while the market for life sciences tools declined in 2012.

Mr. Teich's presentation, 'Growing in a World of Budget Constraints,' will address the challenging markets faced by emerging technology companies that relied on government research funding during a period of high unpredictability in late 2012 and early 2013.

"American research scientists have struggled through difficult times in the past two years with the uncertainties of a presidential election, sequestration, and an unsigned NIH budget – and their funding continues to be in jeopardy.  European research and development support has been equally challenged by the austerity measures throughout the years," stated Mr. Teich.  "Despite this, Seahorse has continued to grow at double-digit rates.  At MipTec I will present the three primary factors that I believe enabled our survival and success in a tough market environment."

Being held 24th - 26th September, 2013, in Basel Switzerland, MipTec is Europe's leading event for drug discovery and life sciences research, providing a platform for strategic and business-oriented networking, and the opportunity for scientists to gain expert insights into new technology, and leading-edge developments that are accelerating life sciences research and drug discovery.  Mr. Teich's presentation is part of the Jumpstarting Innovations in Life Sciences Forum taking place Thursday, 26th September 2013, 9:00 am – 12:00 noon, in Room 1, Exhibition Area Hall 4.1.

Seahorse Bioscience provides industry-leading analytical instruments, and consumable products for biological research and drug discovery. The XFe Extracellular Flux Analyzer and stress test kits are the driving force behind cell-metabolism research, simultaneously measuring the two major energy-producing pathways within the cell – mitochondrial respiration and glycolysis – in real-time, in a microplate. This novel technology enables scientists to better understand the connection of physiological traits of cells with genomic and proteomic data, and this knowledge is generating new insights into mitochondrial function, leading to a greater understanding and treatments of disease. Seahorse Bioscience's Switzerland Distributor Bucher Biotec will represent XF technology at booth C34. 

About MipTec
The MipTec Conference and Exhibition offers professionals in the field of drug discovery and life sciences a platform to discuss and share knowledge about the latest breakthroughs in new technologies that have enabled pharmacogenomics to deliver personalized medicines to some patient populations, as well as cell-based therapies that are advancing to the clinic, and exciting developments in biological engineering that are enabling the interrogation of novel disease mechanisms. Learn more about MipTec.

About Seahorse Bioscience
Seahorse Bioscience XFe Extracellular Flux Analyzers and stress test kits are the industry standard in cellular bioenergetic measurements. Over 2,500 scientists worldwide are advancing their research in understanding the role of cell metabolism in Neurodegeneration, Aging, Cancer, Cardiovascular, Cell Physiology, Toxicology and Hepatobiology, Immunology, Infectious Diseases, Mitochondrial Diseases, Model Organisms, Obesity, Diabetes, Metabolic Disorders, Screening, and Translational Medicine. Founded in 2001, Seahorse Bioscience is headquartered in Billerica, Massachusetts, U.S., and has regional offices in Copenhagen, Denmark; and Shanghai, China. Learn more about Seahorse Bioscience.

Media Contact
Naomi Goumillout
Marketing Communications Manager
Seahorse Bioscience

SOURCE Seahorse Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Seahorse XF Technology Helps P&G Research the Science of Skin
2. Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners Advancing Cell Metabolism Research
3. Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
4. Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
5. Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
6. Perle BioScience Selects BlazeFund As Its Crowd Funding Platform
7. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
8. Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis
9. PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network
10. Genocea Biosciences Selected To Present Late-Breaking Oral Presentation At ICAAC 2013
11. Regado Biosciences, Inc. Announces Closing of Initial Public Offering
Post Your Comments:
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... 2016 The Biotechnology industry might ... present great opportunities to investors. assesses the recent ... (NYSE: XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... receive your complimentary trade alerts at: ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):